Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shukra Pharmaceuticals held a board meeting on August 30, 2025, approving several routine annual items. The company appointed CS Rupal Patel as Secretarial Auditor for a 5-year term starting FY 2025-26 and approved the Director's Report along with the Secretarial Audit Report for FY ending March 31, 2025. The 32nd Annual General Meeting is scheduled for September 29, 2025 at 11:30 am via video conferencing, with the Register of Members closed from September 23 to September 29, 2025. M/s. Shah Sanghvi and Associates were appointed as new Statutory Auditors for a 5-year term, replacing the retiring auditors under the standard rotation requirement.
These are routine annual governance and compliance actions. The auditor change is a standard statutory rotation rather than a mid-term resignation, and no senior management changes were announced, so shareholders should see no material impact on the stock price.